Nov 9 (Reuters) - Organovo Holdings Inc ONVO.O
* Organovo announces fiscal second-quarter 2018 results;
company
shifts commercial focus to higher-value disease modeling
opportunities and updates full-year fiscal 2018 outlook
* Q2 loss per share $0.09
* Q2 revenue $1.4 million versus I/B/E/S view $1.4 million
* Sees FY 2018 revenue $4.5 million to $6.5 million
* Q2 earnings per share view $-0.10 -- Thomson Reuters
I/B/E/S
Source text for Eikon: ID:nGNXOGUQVa
Further company coverage: ONVO.O
((Bangalore.newsroom@thomsonreuters.com;))